Title : Relevance of CYP2B6 and CYP2D6 genotypes to methadone pharmacokinetics and response in the OPAL study.

Pub. Date : 2019 Jul

PMID : 30907440






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Relevance of CYP2B6 and CYP2D6 genotypes to methadone pharmacokinetics and response in the OPAL study. Methadone cytochrome P450 family 2 subfamily B member 6 Homo sapiens
2 AIMS: Our study aimed to evaluate the impacts of the cytochrome P450 (CYP) 2B6-G516T and CYP2D6 genetic polymorphisms on pharmacokinetic and clinical parameters in patients receiving methadone maintenance treatment. Methadone cytochrome P450 family 2 subfamily B member 6 Homo sapiens
3 RESULTS: When comparing the three CYP2B6 genotype groups, the methadone (R)- and (S)-methadone enantiomer concentrations/doses (concentrations relative to doses) were different (P = .029, P = .0019). Methadone cytochrome P450 family 2 subfamily B member 6 Homo sapiens
4 RESULTS: When comparing the three CYP2B6 genotype groups, the methadone (R)- and (S)-methadone enantiomer concentrations/doses (concentrations relative to doses) were different (P = .029, P = .0019). Methadone cytochrome P450 family 2 subfamily B member 6 Homo sapiens
5 CONCLUSION: The genotyping of CYP2B6 G516T could be an interesting tool to explore methadone intervariability. Methadone cytochrome P450 family 2 subfamily B member 6 Homo sapiens